And as studies have proven, Zepbound is more effective than Wegovy in achieving weight loss, and only Zepbound is has been proven effective and approved by the FDA for treating sleep apnea in patients with obesity. The lawsuit seeks to restore coverage of Zepbound for people on CVS Caremark plans and award other appropriate equitable relief. CVS Caremark says the suit is without merit. Well defend ourselves vigorously against those claims, David Whitrap, vice president of external affairs for CVS Health, said in an email
Start with a $49 Consult to see which tier fits
Extending treatment to one year, the gap widens: about 4% greater weight loss in non-diabetics on semaglutide, and about 5.5% greater on tirzepatide. Some researchers suggest that behavioral differences such as motivation, adherence and engagement in lifestyle changes might help explain this gap
However I requested medical records to provide to another doctor for a 2nd opinion
Other significant safety considerations include a history of pancreatitis, acute kidney injury risk, diabetic retinopathy complications in patients with type 2 diabetes, gallbladder disease, hypoglycemia risk in patients using other diabetes medications, and mental health monitoring for mood changes or suicidal ideation
2 Foods to limit or avoid on GLP-1s GLP-1s can cause side effects such as nausea, bloating or diarrhea
